China National Medicines Corp Ltd (600511) - Total Assets
Based on the latest financial reports, China National Medicines Corp Ltd (600511) holds total assets worth CN¥35.13 Billion CNY (≈ $5.14 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of China National Medicines Corp Ltd for net asset value and shareholders' equity analysis.
China National Medicines Corp Ltd - Total Assets Trend (1999–2024)
This chart illustrates how China National Medicines Corp Ltd's total assets have evolved over time, based on quarterly financial data.
China National Medicines Corp Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
China National Medicines Corp Ltd's total assets of CN¥35.13 Billion consist of 86.9% current assets and 13.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 31.2% |
| Accounts Receivable | CN¥14.29 Billion | 40.9% |
| Inventory | CN¥4.96 Billion | 14.2% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥391.56 Million | 1.1% |
| Goodwill | CN¥203.77 Million | 0.6% |
Asset Composition Trend (1999–2024)
This chart illustrates how China National Medicines Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see China National Medicines Corp Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: China National Medicines Corp Ltd's current assets represent 86.9% of total assets in 2024, a decrease from 90.5% in 1999.
- Cash Position: Cash and equivalents constituted 31.2% of total assets in 2024, up from 9.4% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 40.9% of total assets.
China National Medicines Corp Ltd Competitors by Total Assets
Key competitors of China National Medicines Corp Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
China National Medicines Corp Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.15 | 2.04 | 1.97 |
| Quick Ratio | 1.79 | 1.68 | 1.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥16.33 Billion | CN¥15.15 Billion | CN¥10.87 Billion |
China National Medicines Corp Ltd - Advanced Valuation Insights
This section examines the relationship between China National Medicines Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.21 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | 7.6% |
| Total Assets | CN¥34.93 Billion |
| Market Capitalization | $3.16 Billion USD |
Valuation Analysis
Below Book Valuation: The market values China National Medicines Corp Ltd's assets below their book value (0.09x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: China National Medicines Corp Ltd's assets grew by 7.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for China National Medicines Corp Ltd (1999–2024)
The table below shows the annual total assets of China National Medicines Corp Ltd from 1999 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥34.93 Billion ≈ $5.11 Billion |
+7.63% |
| 2023-12-31 | CN¥32.45 Billion ≈ $4.75 Billion |
+9.61% |
| 2022-12-31 | CN¥29.61 Billion ≈ $4.33 Billion |
+7.77% |
| 2021-12-31 | CN¥27.48 Billion ≈ $4.02 Billion |
+10.32% |
| 2020-12-31 | CN¥24.90 Billion ≈ $3.64 Billion |
+2.94% |
| 2019-12-31 | CN¥24.19 Billion ≈ $3.54 Billion |
+12.48% |
| 2018-12-31 | CN¥21.51 Billion ≈ $3.15 Billion |
+6.66% |
| 2017-12-31 | CN¥20.17 Billion ≈ $2.95 Billion |
+172.46% |
| 2016-12-31 | CN¥7.40 Billion ≈ $1.08 Billion |
+12.90% |
| 2015-12-31 | CN¥6.56 Billion ≈ $959.36 Million |
+18.39% |
| 2014-12-31 | CN¥5.54 Billion ≈ $810.36 Million |
+9.03% |
| 2013-12-31 | CN¥5.08 Billion ≈ $743.25 Million |
+11.40% |
| 2012-12-31 | CN¥4.56 Billion ≈ $667.16 Million |
+28.37% |
| 2011-12-31 | CN¥3.55 Billion ≈ $519.72 Million |
+4.68% |
| 2010-12-31 | CN¥3.39 Billion ≈ $496.47 Million |
+22.18% |
| 2009-12-31 | CN¥2.78 Billion ≈ $406.33 Million |
+39.06% |
| 2008-12-31 | CN¥2.00 Billion ≈ $292.21 Million |
+2.09% |
| 2007-12-31 | CN¥1.96 Billion ≈ $286.22 Million |
+43.61% |
| 2006-12-31 | CN¥1.36 Billion ≈ $199.31 Million |
+6.36% |
| 2005-12-31 | CN¥1.28 Billion ≈ $187.39 Million |
+7.35% |
| 2004-12-31 | CN¥1.19 Billion ≈ $174.55 Million |
+9.59% |
| 2003-12-31 | CN¥1.09 Billion ≈ $159.27 Million |
+34.65% |
| 2002-12-31 | CN¥808.37 Million ≈ $118.29 Million |
+85.51% |
| 2001-12-31 | CN¥435.76 Million ≈ $63.77 Million |
+13.83% |
| 2000-12-31 | CN¥382.83 Million ≈ $56.02 Million |
-32.94% |
| 1999-12-31 | CN¥570.85 Million ≈ $83.53 Million |
-- |
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more